GTx competitors

GTx Competitors include Alpine Immune Sciences, G1 Therapeutics, Syndax Pharmaceuticals and Rexahn Pharmaceuticals.
Add company...
GTx
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.
Alpine Immune Sciences
Modern therapies targeting the immune synapse.
G1 Therapeutics
G1 is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer.
Syndax Pharmaceuticals
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
Founding Date
Founding Date
1997
Founding Date
2015
Founding Date
2008
Founding Date
2005
Founding Date
2001
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Memphis, US HQ
Locations
Seattle, US HQ
Locations
Durham, US HQ
Locations
Waltham, US HQ
Locations
Rockville, US HQ
Employees
Employees
26
Employees
N/A
Employees
3827% increase
Employees
3237% decrease
Employees
20
Valuation ($)
Valuation ($)
45 m
Valuation ($)
N/A
Valuation ($)
1.6 b
Valuation ($)
168.9 m
Valuation ($)
37.5 m
Twitter followers
Twitter followers
N/A
Twitter followers
166
Twitter followers
N/A
Twitter followers
108
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$2.1m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($6.9m) (FY, 2016)
Net income
($7.8m) (FY, 2017)
Net income
($60.1m) (FY, 2017)
Net income
($60.8m) (FY, 2017)
Net income
($25.3m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 64.7m
Total funding raised
$ 49.3m
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
$ 5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Alpine Immune Sciences
HQ
Seattle, US

Modern therapies targeting the immune synapse.

View company
G1 Therapeutics
HQ
Durham, US
Employees
38↑ 27% increase

G1 is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer.

View company
Syndax Pharmaceuticals
HQ
Waltham, US
Employees
32↓ 37% decrease

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.

View company
Rexahn Pharmaceuticals
HQ
Rockville, US
Employees
20

Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

View company